| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/14/1998 | US5738839 Package containing gelled particles and inclusion medium, which blend together when dispensed |
| 04/14/1998 | CA2066617C Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| 04/11/1998 | CA2212980A1 Glucomannan-containing orally administered pharmaceutical preparations with sustained effect |
| 04/09/1998 | WO1998014769A1 Stabilizing formulation for preserving the integrity of proteins present in a body fluid |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014478A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 04/09/1998 | WO1998014476A1 Pharmaceutical compositions containing an mpl ligand |
| 04/09/1998 | WO1998014439A1 Piperazine based cytofectins |
| 04/09/1998 | WO1998014399A1 Silicon oxide powder and process for the production thereof, cosmetics made by using the same, micelle-retaining powder, and perfume-retaining powder |
| 04/09/1998 | WO1998014216A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | WO1998014215A2 Glycoconjugates as virus cell adhesion inhibitors |
| 04/09/1998 | WO1998014199A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | WO1998014196A1 Liquid alendronate formulations |
| 04/09/1998 | WO1998014189A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | WO1998014179A1 Taste-masked microcapsule compositions and methods of manufacture |
| 04/09/1998 | WO1998014175A1 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998014173A1 Edible, low calorie compostions of a carrier and an active ingredient and methods for preparation thereof |
| 04/09/1998 | WO1998014171A1 Method for producing liposomes with increased percent of compound encapsulated |
| 04/09/1998 | WO1998014168A2 Dosage form providing a sustained and ascending drug release |
| 04/09/1998 | DE19740733A1 Powder composition containing absorbent resin and peptide |
| 04/09/1998 | DE19641437A1 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung 1,3-bis (N-lactamyl) propane and its pharmaceutical and cosmetic use |
| 04/09/1998 | DE19640062A1 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff The oral composition containing a swellable in aqueous medium matrix least one active pharmaceutical ingredient |
| 04/09/1998 | DE19637936A1 Pharmaceutical composition for mucosal application |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2267370A1 Liquid alendronate formulations |
| 04/09/1998 | CA2267305A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | CA2267248A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/08/1998 | EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives |
| 04/08/1998 | EP0834312A1 Topical medicament containing diclofenac |
| 04/08/1998 | EP0833671A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 04/08/1998 | EP0833667A1 Stabilization of polynucleotide complexes |
| 04/08/1998 | EP0833666A2 Cytomodulating conjugates of members of specific binding pairs |
| 04/08/1998 | EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 04/08/1998 | EP0833663A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
| 04/08/1998 | EP0833644A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 04/08/1998 | EP0833628A1 Novel taxoids |
| 04/08/1998 | EP0833612A1 New pharmaceutical composition with anaesthetic effect |
| 04/08/1998 | EP0833611A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 04/08/1998 | EP0833609A1 Compositions and methods for stabilizing polymers |
| 04/08/1998 | EP0833606A1 Stable hydroalcoholic compositions |
| 04/08/1998 | EP0548344B1 Collagen composites for controlled drug release |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/08/1998 | CN1178554A chemically modified interperon |
| 04/08/1998 | CN1178460A Use of compositions comprising stabilized biologically effective compounds |
| 04/08/1998 | CN1178458A Improvements in or relating to organic compositions |
| 04/08/1998 | CN1178232A Polymer/hydrogen peroxide complexes |
| 04/08/1998 | CN1178106A Cyclosphorin-containing soft capsule preparation |
| 04/08/1998 | CN1037933C Preparation of coated solid medicament form having releasability in large intestine |
| 04/08/1998 | CN1037932C Preparation of oral presentation forms for acid-unstable active compounds |
| 04/08/1998 | CN1037931C Plaster without lead and its preparation |
| 04/07/1998 | US5736625 Method for stabilizing proteins with saccharide linked protein polymer conjugates |
| 04/07/1998 | US5736624 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
| 04/07/1998 | US5736581 Polyglycerol polyricinoleates |
| 04/07/1998 | US5736580 Composition, device, and method for electrotransport agent delivery |
| 04/07/1998 | US5736553 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine |
| 04/07/1998 | US5736542 Pharmaceutical compositions containing a staurosporine |
| 04/07/1998 | US5736506 Mixture with polysaccharide |
| 04/07/1998 | US5736395 Transforming cells in mammal by contacting with complexes comprising an expression cassette and a nitrogen-containing amphiphile |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736161 Pharmaceutical preparation for improving the bioavailability of drugs which are difficult to absorb and a procedure for obtaining it |
| 04/07/1998 | US5736155 Encapsulation of antineoplastic agents in liposomes |
| 04/07/1998 | US5736152 Mixture of biodegradable, non-polymeric, water insoluble material and a biocompatible solvent that solubilizes the non-polymeric material |
| 04/07/1998 | US5736151 Antibiotic oil suspensions |
| 04/07/1998 | US5736142 Alteration of immune response using pan DR-binding peptides |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736127 Polymeric nitrogen-containing drug salt forms for controlled release |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA2217409A1 Pharmaceutical preparations for intranasal administration |
| 04/07/1998 | CA2018229C Carboplatin composition |
| 04/02/1998 | WO1998013436A1 Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition |
| 04/02/1998 | WO1998013399A1 Fluid composition for physiological separations |
| 04/02/1998 | WO1998013136A1 Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
| 04/02/1998 | WO1998013073A1 METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN |
| 04/02/1998 | WO1998013069A2 Fluorinated copolymeric pharmaceutical adjuncts |
| 04/02/1998 | WO1998013059A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| 04/02/1998 | WO1998013056A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | WO1998013055A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 04/02/1998 | WO1998013042A1 Antimycotic gel with high active substance release |
| 04/02/1998 | WO1998013032A1 Compositions of therapeutic agents suitable for oral administration |
| 04/02/1998 | WO1998013031A2 Medicinal aerosol formulations comprising budesonide |
| 04/02/1998 | WO1998013030A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | WO1998013028A1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
| 04/02/1998 | WO1998013024A2 Hyaluronic drug delivery system |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | WO1998013001A1 Intranasal formulations for promoting sleep and method of using the same |
| 04/02/1998 | WO1998012936A1 Tablets containing a sweetening mixture |
| 04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 04/02/1998 | DE19640364A1 Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen Topical agents for the prophylaxis or treatment of bacterial skin infections |
| 04/02/1998 | DE19639816A1 Antimykotische Mittel mit hoher Wirkstofffreisetzung Antifungal agent with high drug release |
| 04/02/1998 | DE19639343A1 Komprimate, enthaltend ein Süßungsmittelgemisch Compacts containing a sweetener |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2266929A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | CA2266898A1 Intranasal formulations for promoting sleep and method of using the same |
| 04/02/1998 | CA2266642A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer |
| 04/02/1998 | CA2266431A1 Medicinal aerosol formulations comprising budesonide |
| 04/02/1998 | CA2264227A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |